Vice President and Medical Director, Geriatrics, Excellus BlueCross BlueShield
Thursday, September 14
Most people near the end of life lack the ability to make their own decisions about the treatments they wish to receive and to avoid. They often receive care after a hospitalization and long-term care from physicians who do not know them. Advance care planning is essential to ensure patients receive care and treatment that reflects their values, beliefs, and goals.
Dr. Bomba will discuss recommendations from the 2014 Institute of Medicine report, Dying in America. She will explain the difference between traditional advance directives like a health care proxy and medical orders, like the Medical Orders for Life-Sustaining Treatment (MOLST).
MOLST is a set of medical orders for seriously ill persons that tell health care professionals the type of care and treatment they are to receive and to avoid in an emergency. All health care professionals must follow MOLST.
Dr. Bomba will also cover eMOLST, New York’s electronic registry, which ensures MOLST is done correctly and is accessible to all clinicians in all settings across the state. New York’s MOLST and eMOLST were developed as a result of a community initiative to improve the quality of care people receive near the end of life.
Dr. Bomba is Vice President and Medical Director, Geriatrics for Excellus BlueCross BlueShield. She served on the Institute of Medicine’s Committee that produced Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life and is a member of the National Academy of Medicine Roundtable on Quality Care for People with Serious Illness.
She chairs the MOLST Statewide Implementation Team and the National Healthcare Decisions Day New York State Coalition and is the NYeMOLST Program Director. She is a founding member, New York’s representative on the National POLST Paradigm Task Force, and chairs the Public Policy Committee.
Dr. Bomba serves on the Medical Society of the State of New York Ethics Committee and NCQA Geriatric Measurement Advisory Panel. She was a member of the American Board of Internal Medicine Primary Palliative Care Committee and the National Quality Forum’s “Framework and Preferred Practices for a Palliative and Hospice Care Quality.”